BiondVax Pharmaceuticals Ltd. BVXV
€ 1.30
0.74%
Geschäftsbericht 2021
hinzugefügt 23.12.2023
BiondVax Pharmaceuticals Ltd. Bilanz 2011-2024 | BVXV
Bilanz Jährlich BiondVax Pharmaceuticals Ltd.
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
- | - | 52 M | 18.5 M | - | -15.7 M | -33.5 M | -9.61 M | -17.9 M | -11 M | - |
Langfristige Schulden |
- | - | 124 M | 94.4 M | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
773 K | 654 K | 694 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | 7.32 M | 162 M | 115 M | 18.6 M | 3.12 M | 6.06 M | 62 K | 55 K | 48 K | - |
Kurzfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | 71.5 M | 181 M | 137 M | 25.4 M | 4.49 M | 7.76 M | 1.88 M | 1.84 M | 1.02 M | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
- | -325 M | -320 M | -211 M | -123 M | -88.9 M | -79.7 M | -69.5 M | -61.7 M | -53.7 M | - |
Vermögenswerte |
99.6 M | 56.9 M | 116 M | 106 M | 81.7 M | 30.1 M | 41.3 M | 18.5 M | 25.8 M | 23.2 M | - |
Zahlungsmittel |
54 M | 9.42 M | 72.5 M | 75.9 M | 71.4 M | 15.7 M | 33.5 M | - | - | - | - |
Buchwert |
99.6 M | -14.6 M | -65.1 M | -31.2 M | 56.3 M | 25.6 M | 33.5 M | 16.6 M | 24 M | 22.2 M | - |
Gesamtes Eigenkapital |
- | -14.6 M | -65.1 M | -31.2 M | 56.3 M | 25.6 M | 33.5 M | - | - | - | - |
Alle Zahlen in ILS-Währung
Bilanz Vierteljährlich BiondVax Pharmaceuticals Ltd.
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 69.1 M | 6.57 M | - | - | 7.32 M | 65.6 M | 141 M | - | 162 M | 137 M | 138 M | - | 115 M | - | - | - | 18.6 M | - | - | - | 3.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
- | - | - | - | -365 M | -354 M | - | - | -325 M | -311 M | -366 M | - | -320 M | -277 M | -258 M | - | -211 M | - | - | - | -123 M | - | - | - | -88.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
- | - | - | - | 99.6 M | 81 M | - | - | 56.9 M | 74.9 M | 85.7 M | - | 116 M | 119 M | 75.8 M | - | 106 M | - | - | - | 81.7 M | - | - | - | 30.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
- | - | - | - | 54 M | 34.7 M | 42.5 M | - | 9.42 M | 24.8 M | 38.8 M | 42.5 M | 72.5 M | 75.2 M | 33.9 M | 57.4 M | 75.9 M | - | - | - | 71.4 M | - | - | - | 15.7 M | - | - | - | 33.5 M | - | - | - | 9.61 M | 192 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
- | - | - | - | 99.6 M | 81 M | - | - | 56.9 M | 74.9 M | 85.7 M | - | 116 M | 119 M | 75.8 M | - | 106 M | - | - | - | 81.7 M | - | - | - | 30.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
- | - | - | - | 23.3 M | 4.19 M | 11.4 M | - | -14.6 M | -1.84 M | -61.9 M | -61.3 M | -65.1 M | -20.4 M | -72.5 M | -30.6 M | -31.2 M | - | - | - | 56.3 M | - | - | - | 25.6 M | - | - | - | 33.5 M | - | - | - | 16.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in ILS-Währung